E815
TEAS SECTION 8 & 15 RECEIVED
06/24/2026
Back to search
Official data from USPTO
RXE2
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RXE2
ST13
US500000088979456Class
35, 39, 42, 44
Filing
88979456
Registration
6235550
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/24/2026
Trademark type
Word
Nice classes
35, 39, 42, 44
Filing date
01/07/2020
Registration date
12/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2020
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/03/2020
First use in commerce
04/03/2020
Drawing code
4
Owner type
03
Owner location
FARGO, ND, US
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RXE2 INC.
RXE2 LLC
Representatives
Joshua G. Gigger STOEL RIVES LLP
Technical classification
Nice Classes
Class 35Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical and pharmacy servicesprocessing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticalsmedical devicesclinical trialshealthcare; maintaining databases of pharmaciespharmacistsother healthcare professionals who can assist with the delivery of pharmaceutical services; promoting the exchange of information and resources within the pharmaceuticalmedical deviceclinical trialmedical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physicianpharmacistother healthcare professional selection decisions; recruitment advertisement servicesposting of clinical trial notices for the purposes of providing clinical trial statusrecruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices
Class 39
Pharmacy packaging servicespackaginglabelingaligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for othersdelivery of medicationdevice and clinical supply packages and containers by date and time and category for patients and healthcare providers
Class 42
Pharmaceutical and medical device servicesproviding pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceuticalbiotechnologymedical device development and testing
Class 44
Dispensing of medications by date and time and category for patients and healthcare providers; population health servicesgathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patientsgroups of patientspopulations; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patientsproviding medication therapy managementmedicinal dosageallergic sensitivityprescription safety information for medical treatment purposes; telepharmacy servicesproviding medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administeringuse and storage of medications; and providing medical information to patients in the form of reports in the field administeringuse and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices
Publications
History of USPTO decisions and trademark events.
28 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/29/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/26/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/25/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/03/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
11/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/26/2020
IUAF
USE AMENDMENT FILED
10/06/2020
DRRR
DIVISIONAL REQUEST RECEIVED
10/06/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/06/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/06/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
ALIE
ASSIGNED TO LIE
04/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/31/2020
GPRA
PRIORITY ACTION E-MAILED
03/31/2020
CPRA
PRIORITY ACTION WRITTEN
03/31/2020
DOCK
ASSIGNED TO EXAMINER
03/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2020
NWAP
NEW APPLICATION ENTERED
01/10/2020
Continuous trademark protection
Get notified about every new filing that threatens RXE2 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.